*Please be aware the venue has changed*

Venue

This year's event will be held in Boston, MA at the Wyndham Boston Beacon Hill.

Screenshot 2026-02-05 121539
Screenshot 2026-02-05 121603
Screenshot 2026-02-05 121726

Room Block Available

We are pleased to announce that for 8th Neuroimmunology Drug Development Summit we have a dedicated room block at the conference hotel,  Wyndham Boston Beacon Hill.

We have a discounted nightly room rate of $259++ from now to March 13th.

The booking reservation contact number is: (877) 999-3223 – please quote / refer to ‘NEUROI0413’ if you are calling in.

Reservations must be made by 13 March which is the cutoff date. However, please note due to high demand, rooms may sell out before the cutoff date so we do recommend you book your accommodation sooner rather than later.

Please email Darja Kielthy at Darja.kielthy@hansonwade.com if you have any questions or queries regarding the room block.

Important Note - Fraudulent Accommodation Booking Scams

We have been made aware that there are third-party companies contacting our conference attendees claiming to represent Hanson Wade Group with fraudulent hotel booking schemes.

Hanson Wade Group does not work with any third parties and accommodation information will only come directly from your Event Manager. For your safety, please only book your accommodation through official links provided by Hanson Wade Group. Learn more in our full accommodation policy: Accommodation Policy - Hanson Wade Group.

IPFsummit-274-768x512
Explore the Agenda

Discover cutting-edge sessions on neuroinflammatory mechanisms, glial biology, peripheral immune targets, and translational biomarkers redefining CNS drug development.

Poster Session
Partner With Us

Connect with senior discovery, preclinical, and translational neuroscientists seeking innovative targets, models, and omics solutions to advance neuroimmunology pipelines.

NIDD Partnership Opportunities
Join Biopharma Experts

Network with industry pioneers shaping the next generation of immune-modulating therapies for neuroinflammatory and neuroimmune disorders.